Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 March, 2017 20:31 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Crude oil price of Indian basket rises marginally - 24-Mar-2017 12:04
TCS, LIBA to launch management program on Business Analytics - 24-Mar-2017 11:56
Asian Oilfield wins LoA for contract worth Rs 1.08 bn - 24-Mar-2017 11:50
NTPC plans to achieve 32 GW installed capacity via renewable sources by 2032 - 24-Mar-2017 10:47
Skipper secures Rs 4.05 bn new orders - 24-Mar-2017 10:30
RCF issues commercial paper worth Rs 1.50 bn - 24-Mar-2017 10:21
Majesco enters into strategic partnership with tier one insurer - 24-Mar-2017 10:16
Bharti Airtel gains on inking definitive agreement with Tikona - 24-Mar-2017 10:06
Ujaas Energy bags order from Indraprastha Power - 24-Mar-2017 09:29
Dilip Buildcon emerges lowest bidder for Rs 32.69 bn road projects - 24-Mar-2017 09:18
NHPC inks purchase pacts with Tata Power - 24-Mar-2017 09:13
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer